Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113888 | 0.93 | FTO (0.52) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL93531 | 0.87 | FTO (0.72) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29838678 | 0.86 | FTO (0.69) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29358729 | 0.86 | FTO (0.69) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL20095 | 0.86 | FTO (0.69) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL29996062 | 0.86 | FTO (0.69) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL31005263 | 0.86 | FTO (0.63) | FTOMAPTMEN1HTTKMT2A | |
| SCHEMBL23158785 | 0.85 | FTO (0.67) | FTOMAPTMEN1HTTKMT2A | |
| Ammonia Solution, Strong SCHEMBL29083296 | 0.85 | FTO (0.67) | FTOMAPTMEN1HTTKMT2A | |
| Water SCHEMBL25247555 | 0.85 | FTO (0.67) | FTOMAPTMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130165350-A1 | SURFACE LINKERS FOR ARRAY SYNTHESIS | AFFYMETRIX, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-7176297-B2 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20040234788-A1 | Photoactivateable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2004-11-25 | — | — | US | disclosed |
| US-6773888-B2 | ARRAY OF OLIGONUCLEOTIDES; FUNCTIONALIZED POLYMER, A PHOTOACTIVATABLE SILANE COMPOUND CAPABLE OF PHOTOCHEMICALLY CROSS-LINKING TO SAID FUNCTIONALIZED POLYMER. | AFFYMETRIX, INC. | 2004-08-10 | — | — | US | disclosed |
| WO-2003087166-A2 | PHOTOACTIVATABLE SILANE COMPOUNDS AND METHODS FOR THEIR SYNTHESIS AND USE | AFFYMETRIX, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030194715-A1 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194715-A1 | Photoactivatable silane compounds and methods for their synthesis and use | PCNA, GMNN, LSS | FTO 2036/4885MAPT 4263/4885MEN1 3806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.